Oxatriazolium-5-olate Activates Soluble Guanylate Cyclase for Endothelial Dysfunction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceutical agents for treating sexual disorders do not effectively promote local NO production or provide a hypotensive effect, making them ineffective for addressing endothelial dysfunction-related issues such as erectile dysfunction.
Innovation Solution
The use of 3-(3-[1,2,4]-triazolo)-oxatriazolium-5-olate as an active ingredient in pharmaceutical compositions to treat sexual disorders, which activates soluble guanylate cyclase and increases cGMP synthesis, thereby improving endothelial function and sexual potency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current pharmaceutical agents are used to treat sexual disorders, then sexual dysfunction symptoms may be temporarily addressed, but they fail to promote local NO production and do not provide hypotensive effect, making them ineffective for addressing endothelial dysfunction
Solution Approach 1:
The patent changes the chemical structure parameter by using oxatriazolium-5-olate derivatives instead of conventional agents. These compounds activate soluble guanylate cyclase and increase cGMP levels, producing both hypotensive effects and improved endothelial function, thereby simultaneously addressing multiple parameters (blood pressure, NO production, endothelial health) that conventional agents fail to modify
Solution Approach 2:
The oxatriazolium-5-olate derivative serves multiple functions: it acts as a vasodilator by activating soluble guanylate cyclase, promotes local NO production, provides hypotensive effect, and improves endothelial function. This multi-functionality resolves the contradiction by making a single agent capable of addressing both sexual dysfunction symptoms and underlying endothelial dysfunction
2Ease of operation
If conventional pharmaceutical agents are administered, then some sexual dysfunction symptoms may be relieved, but local nitric oxide production remains insufficient and blood pressure remains elevated
Solution Approach 1:
The patent introduces oxatriazolium-5-olate as an intermediary substance that activates soluble guanylate cyclase, which in turn increases cGMP levels. This intermediary mechanism indirectly promotes NO production and vasodilation, achieving both symptom relief and increased local NO production through a mediating biochemical pathway rather than direct NO administration
3Reliability
If traditional treatments for sexual disorders are used, then erectile dysfunction may be partially managed, but endothelial dysfunction and hypertension persist
Solution Approach 1:
The patent applies preliminary action by using oxatriazolium-5-olate to pre-condition the vascular system through soluble guanylate cyclase activation and cGMP increase. This preliminary vasodilatory and endothelial-protective action creates a favorable physiological state that enhances subsequent sexual function and prevents endothelial damage, addressing both sexual dysfunction and cardiovascular risk factors in advance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound provides a dose-dependent activation of soluble guanylate cyclase, leading to significant improvements in endothelial function and sexual activity parameters, including reduced blood pressure, increased nitric oxide production, and enhanced sexual performance in animal models.
Implementation Method 1
The compound provides a dose-dependent activation of soluble guanylate cyclase, leading to significant improvements in endothelial function
Implementation Method 2
increased nitric oxide production
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention belongs to the chemical and pharmaceutical industry, including the creation of a new medicinal agent intended to treat sexual disorders, and can be used in the biochemistry, physiology and medicine.